News
-
-
-
PRESS RELEASE
PANCREACTIC CANCER: SUCCESFUL TRIAL AGAINST PANCREATIC CANCER WITH DEFENCE’S ARM-002 ANTI-CANCER VACCINE
Defence Therapeutics Inc. successfully completes pre-clinical trial using its ARM-002 anti-cancer vaccine against pancreatic cancer, showing therapeutic effectiveness and potential benefits -
-
-
-
-
-
PRESS RELEASE
DEFENCE THERAPEUTICS SIGNS WITH GERMAN BASED FMS CONSULT GMBH FOR FINANCING STRATEGY TO SUPPORT DEFENCE PIPELINE GROWTH
Defence Therapeutics Inc. partners with FMS Consult GmbH for financing strategy to support pipeline growth. The company aims to advance growth in developing immune-oncology therapeutics and drug delivery technologies -